These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 12469800)
1. Epidemiology of pancreatic cancer in Northeastern Italy: incidence, resectability rate, hospital stay, costs and survival (1990-1992). Pasquali C; Sperti C; Filipponi C; Pedrazzoli S Dig Liver Dis; 2002 Oct; 34(10):723-31. PubMed ID: 12469800 [TBL] [Abstract][Full Text] [Related]
2. Importance of hospital volume in the overall management of pancreatic cancer. Sosa JA; Bowman HM; Gordon TA; Bass EB; Yeo CJ; Lillemoe KD; Pitt HA; Tielsch JM; Cameron JL Ann Surg; 1998 Sep; 228(3):429-38. PubMed ID: 9742926 [TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
4. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography. Mortensen MB Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296 [TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
6. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744 [TBL] [Abstract][Full Text] [Related]
7. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Orsi GB; Di Stefano L; Noah N Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233 [TBL] [Abstract][Full Text] [Related]
8. [Radical resection in patients with pancreatic head carcinomas. A retrospective survival analysis in a group of 307 subjects]. Ryska M; Strnad R; Belina F; Zavoral M; Sálek C; Hrabal P; Buric I; Lásziková E; Kvicerová H; Jurenka B; Holcátová I Rozhl Chir; 2007 Aug; 86(8):432-9. PubMed ID: 17969981 [TBL] [Abstract][Full Text] [Related]
10. Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy. Balzano G; Capretti G; Callea G; Cantù E; Carle F; Pezzilli R HPB (Oxford); 2016 May; 18(5):470-8. PubMed ID: 27154812 [TBL] [Abstract][Full Text] [Related]
11. A prospective cost analysis of pancreatoduodenectomy. Holbrook RF; Hargrave K; Traverso LW Am J Surg; 1996 May; 171(5):508-11. PubMed ID: 8651397 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic carcinoma incidence and survival in Sweden in 1980-2000: a population-based study of 16,758 hospitalized patients with special reference to different therapies. Linder S; Boström L; Nilsson B Eur J Surg Oncol; 2007 Jun; 33(5):616-22. PubMed ID: 17317081 [TBL] [Abstract][Full Text] [Related]
13. [Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre]. Popiela T; Kedra B; Sierzega M; Kubisz A Zentralbl Chir; 2002 Nov; 127(11):965-70. PubMed ID: 12476370 [TBL] [Abstract][Full Text] [Related]
14. [Use of resources in the treatment of pancreatic cancer]. Graadal O; Schlichting E; Aasen AO; Stadaas JO Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2981-2. PubMed ID: 1700495 [TBL] [Abstract][Full Text] [Related]
15. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Kuhlmann K; de Castro S; van Heek T; Busch O; van Gulik T; Obertop H; Gouma D Surgery; 2006 Feb; 139(2):188-96. PubMed ID: 16455327 [TBL] [Abstract][Full Text] [Related]
16. Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome. Sohn TA; Lillemoe KD; Cameron JL; Pitt HA; Huang JJ; Hruban RH; Yeo CJ Ann Surg; 1999 Mar; 229(3):393-400. PubMed ID: 10077052 [TBL] [Abstract][Full Text] [Related]
17. Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer. Bakens MJ; van Gestel YR; Bongers M; Besselink MG; Dejong CH; Molenaar IQ; Busch OR; Lemmens VE; de Hingh IH; Br J Surg; 2015 Dec; 102(13):1670-5. PubMed ID: 26437024 [TBL] [Abstract][Full Text] [Related]
18. Financial Impact of Postoperative Complication Following Hepato-Pancreatico-Biliary Surgery for Cancer. Gani F; Hundt J; Makary MA; Haider AH; Zogg CK; Pawlik TM Ann Surg Oncol; 2016 Apr; 23(4):1064-70. PubMed ID: 26714947 [TBL] [Abstract][Full Text] [Related]
19. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492 [TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]